Evidence map›Paper›PMID 42866229›Full record

ArticlePhysics and imaging in radiation oncology2026

Efficient deep learning-driven workflows for accelerated single-fraction radiation therapy planning of a solitary tumour in the lung.

Mathieu Gaudreault, Nicholas Hardcastle, Katrina Woodford, Jason Li, Kenton Thompson, Susan Harden, Sandro Porceddu, Vanessa Panettieri

Abstract read
In one paragraph

Article in Physics and imaging in radiation oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Mathieu GaudreaultPeter MacCallum Cancer Centre, Melbourne, Victoria 3000, Australia.
Nicholas HardcastlePeter MacCallum Cancer Centre, Melbourne, Victoria 3000, Australia.
Katrina WoodfordPeter MacCallum Cancer Centre, Melbourne, Victoria 3000, Australia.
Jason LiPeter MacCallum Cancer Centre, Melbourne, Victoria 3000, Australia.
Kenton ThompsonPeter MacCallum Cancer Centre, Melbourne, Victoria 3000, Australia.
Susan HardenPeter MacCallum Cancer Centre, Melbourne, Victoria 3000, Australia.
Sandro PorcedduPeter MacCallum Cancer Centre, Melbourne, Victoria 3000, Australia.
Vanessa PanettieriPeter MacCallum Cancer Centre, Melbourne, Victoria 3000, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and Purpose: Same-day, single-fraction radiotherapy requires efficient planning. We introduce two deep learning (DL) dose prediction-driven workflows to generate clinically acceptable plans for treating metastases in the lung. Materials and methods: Consecutive patients treated for a tumour in the lung (11/2018-11/2024) were considered. One workflow used the computed tomography density map and a synthetic dose built from the tumour segmentation as inputs for the DL model [ Results: Training and testing datasets contained 200 and 56 treatments, respectively. Without- / with-OOI workflows generated plans in 8.8 and 9.6 min. The 3%/3 mm gamma passing rates between predicted and clinical doses were median ± interquartile range 99.4 ± 0.7% / 99.3 ± 0.8%. After dose optimisation in the TPS, 25% of plans had a higher number of achieved clinical goals relative to clinical plans in both workflows. The conformity was improved (CI Conclusions: Workflows driven by DL dose prediction could generate a clinically acceptable plan in less than ten minutes for same-day, single-fraction treatment of a tumour in the lung.

Indexed as

Artificial intelligenceAutosegmentationDeep learningDose predictionMetastatic lung cancerTreatment plan

Identifiers

PMID42866229
PMCPMC13657210

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.